ELIZABETH RIPLEY

Summary

Affiliation: Virginia Commonwealth University
Country: USA

Publications

  1. pmc Training NIH K award recipients: the role of the mentor
    ELIZABETH RIPLEY
    Division of Nephrology, Virginia Commonwealth University, Richmond, Virginia, USA
    Clin Transl Sci 5:386-93. 2012
  2. pmc Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
    ELIZABETH RIPLEY
    Division of Nephrology, Virginia Commonwealth University, Richmond, Virginia, USA
    Int J Nephrol Renovasc Dis 3:93-8. 2010
  3. pmc EMS providers and exception from informed consent research: benefits, ethics, and community consultation
    ELIZABETH RIPLEY
    Department of Internal Medicine, Division of Nephrology, Virginia Commonwealth University, Richmond, Virginia 23298, USA
    Prehosp Emerg Care 16:425-33. 2012
  4. doi request reprint Guiding the next generation of NIH investigators in responsible conduct of research: the role of the mentor
    ELIZABETH RIPLEY
    Virginia Commonwealth University, Richmond, Virginia 23298, USA
    Account Res 19:209-19. 2012
  5. doi request reprint Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease
    ELIZABETH RIPLEY
    Division of Nephrology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298 0565, USA
    Am Heart J 157:S7-S16. 2009
  6. pmc Why do we pay? A national survey of investigators and IRB chairpersons
    ELIZABETH RIPLEY
    Division of Nephrology, Virginia Commonwealth University, USA
    J Empir Res Hum Res Ethics 5:43-56. 2010
  7. pmc Who's doing the math? Are we really compensating research participants?
    ELIZABETH RIPLEY
    Division of Nephrology, Virginia Commonwealth University, USA
    J Empir Res Hum Res Ethics 5:57-65. 2010

Research Grants

  1. Modeling Research Participant Compensation
    ELIZABETH RIPLEY; Fiscal Year: 2007
  2. Community Partnership for Ethical Research
    ELIZABETH B RIPLEY; Fiscal Year: 2010

Detail Information

Publications7

  1. pmc Training NIH K award recipients: the role of the mentor
    ELIZABETH RIPLEY
    Division of Nephrology, Virginia Commonwealth University, Richmond, Virginia, USA
    Clin Transl Sci 5:386-93. 2012
    ..This study was designed to determine characteristics of NIH mentored K award recipients and their mentors, their interpersonal interactions, and the factors, which influence satisfaction within this relationship...
  2. pmc Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
    ELIZABETH RIPLEY
    Division of Nephrology, Virginia Commonwealth University, Richmond, Virginia, USA
    Int J Nephrol Renovasc Dis 3:93-8. 2010
    ..This review presents the physiological effects of losartan on the kidney and discusses relevant clinical outcomes...
  3. pmc EMS providers and exception from informed consent research: benefits, ethics, and community consultation
    ELIZABETH RIPLEY
    Department of Internal Medicine, Division of Nephrology, Virginia Commonwealth University, Richmond, Virginia 23298, USA
    Prehosp Emerg Care 16:425-33. 2012
    ....
  4. doi request reprint Guiding the next generation of NIH investigators in responsible conduct of research: the role of the mentor
    ELIZABETH RIPLEY
    Virginia Commonwealth University, Richmond, Virginia 23298, USA
    Account Res 19:209-19. 2012
    ..We conclude the mentor's role is important but not optimal based on the results of our study cohort...
  5. doi request reprint Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease
    ELIZABETH RIPLEY
    Division of Nephrology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298 0565, USA
    Am Heart J 157:S7-S16. 2009
    ..There is accumulating clinical evidence that the combination of an ACEI and an ARB provides greater renal protection, particularly in decreasing proteinuria, than does either agent alone...
  6. pmc Why do we pay? A national survey of investigators and IRB chairpersons
    ELIZABETH RIPLEY
    Division of Nephrology, Virginia Commonwealth University, USA
    J Empir Res Hum Res Ethics 5:43-56. 2010
    ..Payment models varied by type of study. Ranges for recommended payments by both groups for different types of procedures and studies are presented...
  7. pmc Who's doing the math? Are we really compensating research participants?
    ELIZABETH RIPLEY
    Division of Nephrology, Virginia Commonwealth University, USA
    J Empir Res Hum Res Ethics 5:57-65. 2010
    ..Results suggest that compensation and reimbursement as the primary reasons for paying research participants may not match actual practice...

Research Grants5

  1. Modeling Research Participant Compensation
    ELIZABETH RIPLEY; Fiscal Year: 2007
    ..An R01 proposal will be submitted to further develop and test this model for feasibility, usefulness and practicality. ..
  2. Community Partnership for Ethical Research
    ELIZABETH B RIPLEY; Fiscal Year: 2010
    ....